Psychiatry and Neurology, Neurology · Anaheim, CA
NPI
1720155641
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
441 N Lakeview Ave
Anaheim, CA, 92807
Phone (888) 988-2800
Groups this clinician bills Medicare through
Medicare paid, 2022
$570
19 services
Medicare patients, 2022
11
Average age 61
Drug cost, 2024
$1.1M
3,087 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin D Spurgeon prescribed most often to Medicare patients was Memantine Hcl, with 258 prescriptions and refills. In total Benjamin D Spurgeon wrote 3,087 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Memantine Hcl Generic | 258 | 655 | 79 | $4,480 |
| Donepezil Hcl Generic | 215 | 638 | 81 | $4,356 |
| Lamotrigine Generic | 206 | 647 | 60 | $8,238 |
| Levetiracetam Generic | 174 | 532 | 67 | $10K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 171 | 510 | 58 | $13K |
| Gabapentin Generic | 121 | 333 | 41 | $3,727 |
| Levetiracetam Er Levetiracetam | 115 | 347 | 36 | $11K |
| Divalproex Sodium Generic | 96 | 233 | 34 | $6,004 |
| Carbamazepine Er Carbamazepine | 91 | 248 | 26 | $15K |
| Topiramate Generic | 81 | 241 | 26 | $2,452 |
| Ropinirole Hcl Generic | 77 | 204 | 22 | $1,539 |
| Clonazepam Generic | 68 | 68 | 12 | $618 |
| Zonisamide Generic | 66 | 204 | 22 | $4,492 |
| Sumatriptan Succinate Generic | 64 | 64 | 15 | $601 |
| Epidiolex Cannabidiol (Cbd) | 63 | 67 | Under 11 | $250K |
Brand drugs: - claims; generic drugs: 2,819 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Benjamin D Spurgeon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.